Open an account

Apimeds Pharmaceuticals US

APUS · NYSE American

$3.41+$0.09 (+2.71%)TodayMarket closed ·
Prev close $3.32

About APUS

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.

Employees
2
Headquarters
Matawan, New Jersey
Listed
May 9, 2025
Sector
Health Care
Industry
Biotechnology
Website
apimedsus.com

APUS key statistics

Market cap
5.15M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
11.64M
Volume
173
Open price
$3.43
High today
$3.55
Low today
$3.21
52 Week high
$59.70
52 Week low
$1.51

Apimeds Pharmaceuticals US (APUS) at a glance

Apimeds Pharmaceuticals US (APUS) last traded at $3.41, with a market cap of 5.15M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.21 and $3.55. The current price is 6.2% above the day's low and 3.9% below its high.

Volume so far is 173 shares, below the average of 11.64M shares a day.

Over the past year Apimeds Pharmaceuticals US has ranged from $1.51 to $59.70, and now sits 3% of the way up that range.

APUS news

  • Akanksha Bakshi

    Why Is Apimeds Pharmaceuticals Stock Gaining Monday?

  • Shivdeep Dhaliwal

    Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Investors' Radars Today

  • Avi Kapoor

    Crude Oil Rises Over 4%; Darden Earnings Miss Views

  • Henry Khederian

    Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?

  • Avi Kapoor

    Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000

  • Press releaseGlobe Newswire

    IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as Apimeds Pharmaceuticals US

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.